Monday, October 5, 2009

GlaxoSmithKline Gets FDA Panel Recommendation For Kidney Cancer ... - RTT News


GlaxoSmithKline Gets FDA Panel Recommendation For Kidney Cancer ...
RTT News
... a volume of 0.985 million shares on the NYSE, and in the after hours trading the stock price increased to $39.10 up $0.24 or 0.62%. by RTT Staff Writer.

and more »

No comments:

Post a Comment